Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Jain

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
International Journal of Molecular Sciences|April 3, 2021
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying BiologyTheodoros Karantanos, Tania Jain, Alison R Moliterno, et al.
Human Pathology|May 11, 2025
Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: Histologic features and morphologic mimicsSaman S Karimi, Tatianna C Larman, Tania Jain, et al.
Annals of Hematology|May 27, 2016
Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximabTania Jain, Jisha John, Aditya Kotecha, et al.
American Journal of Hematology|July 24, 2018
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysisTalal Hilal, Zhen Wang, Diana Almader-Douglas, et al.
Transplantation and Cellular Therapy|July 25, 2022
Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving PerspectiveScott R Goldsmith, Armin Ghobadi, John F Dipersio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 25, 2018
Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-AnalysisTania Jain, Fares Alahdab, Belal Firwana, et al.
Research Square|May 18, 2026
Incidence, Prevalence, and Survival Outcomes of Patients with Myeloproliferative Neoplasms in the United States: a SEER database analysis, years 2000-2021Pankit Vachhani, Sachi Singhal, Rahul Mishra, et al.
Blood Advances|May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor ageAlexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.
European Journal of Ophthalmology|February 2, 2024
Long term follow up of patients with MNV3 treated with intra-vitreal AfliberceptAndrew C Browning, Michael E Grinton, Stephanie Quinn, et al.
Transplantation and Cellular Therapy|December 26, 2021
American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell TherapyTania Jain, Tristan Knight, Maritza C Alencar, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|April 3, 2021
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying BiologyTheodoros Karantanos, Tania Jain, Alison R Moliterno, et al.
Human Pathology|May 11, 2025
Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: Histologic features and morphologic mimicsSaman S Karimi, Tatianna C Larman, Tania Jain, et al.
Annals of Hematology|May 27, 2016
Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximabTania Jain, Jisha John, Aditya Kotecha, et al.
American Journal of Hematology|July 24, 2018
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysisTalal Hilal, Zhen Wang, Diana Almader-Douglas, et al.
Transplantation and Cellular Therapy|July 25, 2022
Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving PerspectiveScott R Goldsmith, Armin Ghobadi, John F Dipersio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 25, 2018
Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-AnalysisTania Jain, Fares Alahdab, Belal Firwana, et al.
Research Square|May 18, 2026
Incidence, Prevalence, and Survival Outcomes of Patients with Myeloproliferative Neoplasms in the United States: a SEER database analysis, years 2000-2021Pankit Vachhani, Sachi Singhal, Rahul Mishra, et al.
Blood Advances|May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor ageAlexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.
European Journal of Ophthalmology|February 2, 2024
Long term follow up of patients with MNV3 treated with intra-vitreal AfliberceptAndrew C Browning, Michael E Grinton, Stephanie Quinn, et al.
Transplantation and Cellular Therapy|December 26, 2021
American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell TherapyTania Jain, Tristan Knight, Maritza C Alencar, et al.
Pageof 12